BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang XY, Luo Y, Wen TF, Jiang L, Li C, Zhong XF, Zhang JY, Ling WW, Yan LN, Zeng Y, Wu H. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment. World J Gastroenterol 2014; 20(35): 12628-12636 [PMID: 25253968 DOI: 10.3748/wjg.v20.i35.12628]
URL: https://www.wjgnet.com/1948-5182/full/v20/i35/12628.htm
Number Citing Articles
1
Christopher D. Malone, Robert F. Mattrey, David T. Fetzer. Contrast-Enhanced Ultrasound (CEUS) for the Diagnosis and Management of Hepatocellular Carcinoma: Current Status and Future TrendsCurrent Hepatology Reports 2016; 15(4): 307 doi: 10.1007/s11901-016-0324-8
2
Qiuyang Li, Zhongxin Wang, Xin Ma, Jie Tang, Yukun Luo. Diagnostic accuracy of contrast-enhanced ultrasound for detecting bland thrombus from inferior vena cava tumor thrombus in patients with renal cell carcinomaInternational braz j urol 2020; 46(1): 92 doi: 10.1590/s1677-5538.ibju.2019.0304
3
Xavier Serres-Creixams, Joan Vidal-Jove, Timothy J. Ziemlewicz, Jonathan M. Cannata, Jose Miguel Escudero-Fernandez, Iciar Uriarte, Carolina Alemany-Botelho, Nuria Roson, Manuel Escobar. Contrast-Enhanced Ultrasound: A Useful Tool to Study and Monitor Hepatic Tumors Treated With HistotripsyIEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 2021; 68(9): 2853 doi: 10.1109/TUFFC.2021.3073540
4
Luciano Tarantino, Pasquale Ambrosino, Matteo Nicola Dario Di Minno. Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(32): 9457-9460 doi: 10.3748/wjg.v21.i32.9457
5
Laura Iliescu. Liver Diseases2020; : 503 doi: 10.1007/978-3-030-24432-3_44
6
Yan Feng, Xia-Chuan Qin, Yan Luo, Yong-Zhong Li, Xiang Zhou. Efficacy of Contrast-Enhanced Ultrasound Washout Rate in Predicting Hepatocellular Carcinoma DifferentiationUltrasound in Medicine & Biology 2015; 41(6): 1553 doi: 10.1016/j.ultrasmedbio.2015.01.026
7
Matteo Renzulli, Rita Golfieri. Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver diseaseJournal of Gastroenterology and Hepatology 2016; 31(1): 69 doi: 10.1111/jgh.13150
8
Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo. Current role of intraoperative ultrasonography in hepatectomySurgery Today 2021; 51(12): 1887 doi: 10.1007/s00595-020-02219-9
9
Antonio Giorgio, Valentina Giorgio, Paolo Matteucci. Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!Journal of Hepatology 2015; 62(6): 1452 doi: 10.1016/j.jhep.2015.01.042
10
Ji Hoon Park, Mi-Suk Park, So Jung Lee, Woo Kyoung Jeong, Jae Young Lee, Min Jung Park, Kyunghwa Han, Chung Mo Nam, Seong Ho Park, Kyoung Ho Lee. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trialBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3267-8
11
Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Fabio Sandomenico, Maria Luisa Barretta, Andrea Belli, Raffaele Palaia, Fabiana Tatangelo, Roberta Grassi, Francesco Izzo, Antonella Petrillo. Major and ancillary features according to LI-RADS in the assessment of combined hepatocellular-cholangiocarcinomaRadiology and Oncology 2020; 54(2): 149 doi: 10.2478/raon-2020-0029